Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HEPALIFE TECHNOLOGIES INC | 7,342,377 | reported | 11 Apr 2017 | tx 5+5,812,760 |
| CRISPR Therapeutics AG | 4,173,019 | reported | 21 Nov 2018 | tx 27+9,669,960−9,182,106 |
| Jounce Therapeutics, Inc. | 2,831,463 | reported | 01 Feb 2017 | tx 3+3,456,463−10,448,100 |
| AGIOS PHARMACEUTICALS, INC. | 1,374,599 | reported | 23 Jan 2018 | tx 7+6,194,988−11,030,047 |
| ACCELERON PHARMA INC | 0 | reported | 09 Jul 2020 | tx 16+6,971,772−2,526,037 |
| SUTRO BIOPHARMA, INC. | 0 | reported | 01 Oct 2018 | tx 5+1,726,197−48,007,412 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jul 2020 | EXERCISE | ACCELERON PHARMA INC | 38,979 | 5.88 USD | |
| 09 Jul 2020 | SALE | ACCELERON PHARMA INC | 2,241 | 102.28 USD | |
| 09 Jul 2020 | EXERCISE | ACCELERON PHARMA INC | 38,979 | 0.00 USD | deriv |
| 01 Jul 2020 | PURCHASE | ACCELERON PHARMA INC | 108,108 | 92.50 USD | first after silence |
| 18 Jan 2019 | PURCHASE | ACCELERON PHARMA INC | 706,206 | 43.00 USD | |
| 01 Oct 2018 | CONVERSION | SUTRO BIOPHARMA, INC. | 1,726,197 | — | |
| 01 Oct 2018 | CONVERSION | SUTRO BIOPHARMA, INC. | 18,726,075 | 0.00 USD | deriv |
| 01 Oct 2018 | CONVERSION | SUTRO BIOPHARMA, INC. | 2,845,114 | 0.00 USD | deriv |
| 01 Oct 2018 | CONVERSION | SUTRO BIOPHARMA, INC. | 8,338,892 | 0.00 USD | deriv |
| 01 Oct 2018 | CONVERSION | SUTRO BIOPHARMA, INC. | 18,097,331 | 0.00 USD | deriv |
| 23 Jan 2018 | PURCHASE | AGIOS PHARMACEUTICALS, INC. | 851,154 | 67.00 USD | |
| 06 Nov 2017 | SALE | CRISPR Therapeutics AG | 79,327 | 18.89 USD | |
| 01 Dec 2017 | SALE | CRISPR Therapeutics AG | 87,991 | 19.10 USD | |
| 30 Nov 2017 | SALE | CRISPR Therapeutics AG | 12,666 | 19.04 USD | |
| 29 Nov 2017 | SALE | CRISPR Therapeutics AG | 4,263 | 19.25 USD | |
| 28 Nov 2017 | SALE | CRISPR Therapeutics AG | 5,080 | 19.22 USD | |
| 27 Nov 2017 | SALE | CRISPR Therapeutics AG | 27,990 | 19.75 USD | |
| 24 Nov 2017 | SALE | CRISPR Therapeutics AG | 26,010 | 20.00 USD | |
| 22 Nov 2017 | SALE | CRISPR Therapeutics AG | 256,000 | 19.76 USD | |
| 21 Nov 2018 | SALE | CRISPR Therapeutics AG | 80,000 | 19.25 USD | |
| 20 Nov 2017 | SALE | CRISPR Therapeutics AG | 158,718 | 19.02 USD | |
| 17 Nov 2017 | SALE | CRISPR Therapeutics AG | 51,282 | 18.44 USD | |
| 16 Nov 2017 | SALE | CRISPR Therapeutics AG | 105,000 | 18.39 USD | |
| 03 Nov 2017 | SALE | CRISPR Therapeutics AG | 22,759 | 19.10 USD | |
| 04 Dec 2017 | SALE | CRISPR Therapeutics AG | 30,485 | 19.47 USD |
1 purchase reported after at least 12 months of silence — most recent on 01 Jul 2020.